Keyword: R&D

News

Management Reshuffle at GlaxoSmithKline

12.01.2018 - A management reshuffle at the UK’s largest drugmaker, GlaxoSmithKline has caught the market’s attention, especially as it was carried through by closely watched CEO Emma Walmsley...

News

Teva Confirms Massive Cost Cuts, Job Losses

15.12.2017 - As had been widely expected, Israel-headquartered Teva Pharmaceuticals – world’s largest generics producer – announced on Dec. 14 it would slash 14,000 jobs, about a quarter of its...

News

Bayer Combines Pharma R&D in one Unit

13.12.2017 - From Jan. 1, 2018, Bayer will streamline its strategic pharmaceutical research and development activities and combine them under a single unit covering the therapeutic areas...

News

UK Life Science Boom despite Brexit?

05.12.2017 - As a UK Parliament-select committee prepared for a public evidence session on Dec. 5, examining scenarios for trading arrangements with the UK post-Brexit, reports were circulating...

News

Teva Realigns, may Slash 25% of Workforce

04.12.2017 - Kåre Schultz, new chief executive officer of debt-plagued Israeli drugmaker Teva, is moving rapidly to make good on his pledge to improve the company’s financial performance and...

News

FDA Approves new Two-drug HIV Treatment

29.11.2017 - The US Food and Drug Administration (FDA) has approved a new two-drug regimen for HIV that reports suggest could shake up the $22 billion market for products to treat the immune...

News

Sasol Refocuses, Exits Shale and GTL

28.11.2017 - Following an evaluation of its portfolio, South African energy and chemical company Sasol has decided to focus on high-value specialty chemicals and withdraw from shale gas and gas...

News

Kemira Invests in Oil Recovery Polymers

28.11.2017 - Finland’s Kemira will spend roughly €30 million to expand its capacity of polymers for Chemical Enhanced Oil Recovery (CEOR) at its site in Botlek, the Netherlands. The additional...